UnitedHealth Group (NYSE:UNH) updated its FY 2020
Pre-Market earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 16.25-16.55 for the period, compared to the Thomson Reuters consensus estimate of $16.45. UnitedHealth Group also updated its FY20 guidance to $16.25-16.55 EPS.
Several brokerages have recently weighed in on UNH. Raymond James increased their price target on UnitedHealth Group from $300.00 to $320.00 and gave the company a buy rating in a research note on Thursday, December 5th. ValuEngine raised UnitedHealth Group from a sell rating to a hold rating in a research note on Wednesday, October 2nd. UBS Group increased their price target on UnitedHealth Group from $279.00 to $304.00 and gave the company a neutral rating in a research note on Thursday. Citigroup increased their price target on UnitedHealth Group from $286.00 to $346.00 and gave the company a buy rating in a research note on Thursday. Finally, Piper Jaffray Companies increased their price target on UnitedHealth Group from $312.00 to $325.00 and gave the company an overweight rating in a research note on Wednesday, December 4th. Five analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company’s stock. The company currently has an average rating of Buy and an average target price of $313.50.
NYSE UNH traded down $0.09 during trading hours on Thursday, hitting $296.32. 779,548 shares of the company’s stock were exchanged, compared to its average volume of 2,752,997. The stock has a 50-day simple moving average of $288.46 and a 200 day simple moving average of $255.03. UnitedHealth Group has a 1-year low of $208.07 and a 1-year high of $300.00. The firm has a market cap of $273.08 billion, a price-to-earnings ratio of 23.01, a PEG ratio of 1.37 and a beta of 0.65. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67.
The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a $1.08 dividend. The ex-dividend date was Friday, December 6th. This represents a $4.32 annualized dividend and a yield of 1.46%. UnitedHealth Group’s payout ratio is currently 33.54%.
In other UnitedHealth Group news, CAO Thomas E. Roos sold 1,177 shares of the stock in a transaction that occurred on Thursday, November 7th. The stock was sold at an average price of $255.04, for a total value of $300,182.08. Following the transaction, the chief accounting officer now owns 21,687 shares in the company, valued at $5,531,052.48. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP D Ellen Wilson sold 7,400 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $272.77, for a total value of $2,018,498.00. 0.87% of the stock is currently owned by corporate insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Guidelines for Successful Channel Trading
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.